2021-roundup-and-2022-predictions-in-clinical-research-and-health

a-data-driven-personalized-approach-to-chronic-care-blog

a-look-at-the-covid-19-research-community

Accelerating progress in Parkinson's disease research

as-smart-lens-program-matures-verily-takes-over-program-for-next-phase-of-development

baseline-covid-19-pilot-program-shares-early-screening-and-testing-progress

baseline-covid-19-testing-program-hits-milestone-with-millionth-test

baseline-sleep-mission-results89

verily-advisory-board-series

Reframing evidence generation around the patient journey

Capturing health information with Study Watch

Data for All of Us

Debug Fresno

Design at the intersection of health and tech

Designing a wearable for clinical research

Introducing OneFifteen ProgressBar

Launching a powerful new screening tool for diabetic eye disease in India

The Verily Health Equity Center of Excellence: Addressing Demographic Disparities in Healthcare, By Design

Verily Advisory Board series: Linda Avey discusses health data sharing & ownership

Verily joins The Michael J. Fox Foundation's Parkinson’s Progression Markers Initiative

Verily Study Watch Receives FDA 510(k) Clearance for ECG

bugout-wolbachia-launches-in-the-british-virgin-islands-blog

california-opens-two-new-community-based-covid-19-testing-sites

celebrating-together-baseline-health-study-s-four-year-anniversary-event

dcri-verily-and-hero-registry-to-support-long-term-safety-study-of-covid-19-vaccine93

deepening-our-understanding-of-ms-with-biosensors

deepmass-a-new-machine-learning-method-for-the-characterization-of-proteins

developing-smarter-covid-19-testing-to-inform-public-health

early-detection-for-diabetic-retinopathy-and-diabetic-macular-edema

establishing-a-new-baseline-of-health-and-research-participation-for-diverse-populations-blog

Eyes: a window into heart health

first-patients-screened-with-verily-s-retinal-service-on-world-sight-day-blog

going-big-with-nanoparticle-technology-in-coronary-artery-disease

health-disparities-intensified-by-the-covid-19-pandemic-and-efforts-to-mitigate

health-study-sleep-mission

healthy-at-work-launches-vaccine-management-tool99

how-broad-and-verily-are-creating-tools-together-to-enable-data-sharing-and-analysis-blog

A Verily roundtable: Innovating in healthcare with diversity by design

learning-about-social-determinants-of-health-with-california-surgeon-general-dr-nadine-burke-harris

measuring-verily-s-impact-in-a-year-like-no-other

meet-ilia-tulchinsky-verily-engineering-director-and-canada-site-lead

new-baseline-covid-19-research-project-launches

onduo-is-on-a-mission-to-make-healthy-easy97

one-of-the-smallest-most-discreet-continuous-glucose-monitoring-cgm-systems-receives-fda-clearance-blog

one-verily-forward-blog

Blog: One year, one mission

powering-all-of-us-with-the-nih-vanderbilt-university-and-the-broad-institute-blog

project-baseline-health-study-s-innovative-approach-highlighted-in-nature

protocol-digitization-what-exactly-is-this-transformative-ctms-feature

q-a-with-dana-cho-chief-design-officer-at-verily-on-the-role-of-user-experience-in-healthcare

returning-heart-health-data-to-health-study-participants

singapore-prime-minister-lee-hsien-loong-visits-verily-s-mosquito-sex-sorting-operations-at-the-environmental-health-institute

Solving burnout and tech  overload in clinical research

stephen-gillett-begins-tenure-as-verily-ceo-blog

study-watch-another-step-closer-to-powering-precision-health-blog

the-baseline-covid-19-program-releases-guide-for-establishing-community-testing

the-project-baseline-covid-19-program-responding-to-a-health-crisis

The Promise of Precision Health

Update on our Smart Lens program with Alcon

verily-and-sosei-heptares-show-early-results-in-identifying-gpcr-targets-for-immune-mediated-diseases-blog

verily-appoints-alix-hart-as-chief-marketing-officer-blog

verily-expands-baseline-covid-19-testing-program-to-130-locations-nationwide-providing-over-256-844-tests

verily-expands-stephen-gillett-s-role-to-president-and-chief-operating-officer

verily-launches-covid-19-pathfinder-to-automate-frontline-support

verily-launches-study-to-evaluate-an-obstructive-sleep-apnea-osa-management-platform

verily-partners-with-janssen-to-launch-covid-19-immune-response-study98

verily-receives-emergency-use-authorization-eua-for-pooled-testing-and-publishes-covid-19-guidance

verily-research-interns-explore-social-determinants-of-health-with-a-focus-on-inequities-in-maternal-care

verily-s-baseline-platform-investing-in-security-and-privacy64

verily-s-project-baseline-ready-to-support-healthcare-workers-and-the-hero-research-program

verily-s-support-of-rite-aid-s-expansion-of-covid-19-test-sites65

verily-stands-up-clia-certified-lab-focused-on-covid-19-testing

verily-undertakes-cybersecurity-center-of-excellence-with-stephen-gillett-at-the-helm

verily-welcomes-stephen-gillett-as-chief-operating-officer-to-increase-operational-excellence

Visiting the Personalised Parkinson's Project

waymo-providing-covid-19-testing-to-our-team-in-partnership-with-verily

wrapping-up-debug-fresno-2017

Numetric Thank You

Verily Appoints Andrew Trister, MD, PhD as Chief Scientific Officer

Announcing Coefficient, a Verily Subsidiary Focused on Employer Stop-Loss and Backed by Swiss Re Corporate Solutions

Atlanta University Center Consortium (AUCC) provides its colleges with integrated COVID-19 testing, symptom screening and data analytics through Verily’s Healthy at Work program

colgate-palmolive-to-leverage-verily-s-baseline-platform-for-innovative-study-in-oral-health-research

Georgiamune and Verily announce strategic partnership to advance novel cancer treatment

granular-insurance-company-previously-coefficient-insurance-company-verily-and-swiss-re-corporate-solutions-close-investment-transaction

highmark-health-engages-verily-to-reinvent-the-healthcare-experience-for-highmark-health-customers-and-clinicians

highmark-health-launches-diabetes-management-program-with-onduo-by-verily

Verily and Kyverna Therapeutics announce collaboration to advance cell therapy for autoimmune diseases

Verily appoints Laura O’Donnell as General Counsel

mayo-clinic-verily-to-build-advanced-clinical-decision-support-to-enhance-care

morehouse-college-announces-575-000-endowed-life-sciences-scholarship-from-verily

Onduo and Fitbit collaborate to provide Onduo members with Fitbit devices and services to help manage their holistic health

onduo-by-verily-and-sword-health-partner-to-accelerate-adoption-of-comprehensive-precision-care-approach

otsuka-and-verily-expand-collaboration-on-novel-clinical-trials-solutions-to-accelerate-research-in-major-depressive-disorder

resmed-verily-to-form-joint-venture-to-help-reach-millions-of-untreated-sleep-apnea-sufferers-press

sanofi-and-verily-life-sciences

verily-life-sciences-launches-liftware-level-device

Gilead-and-verily-announce-scientific-collaboration

verily-announces-800m-investment-by-temasek

Sosei Heptares and Verily nominate first G-protein-coupled receptor target for therapeutic development

sosei-heptares-and-verily-will-collaborate-to-generate-novel-drug-candidates-against-gpcr-targets-for-immune-mediated-diseases

The American Heart Association’s Go Red for Women and Verily’s Project Baseline Collaborate to Include More Women in Scientific Research

U.S. Centers for Disease Control and Prevention selects Verily to support national wastewater monitoring

verily-accelerates-technology-and-commercial-growth-with-new-operations-hub-in-dallas

verily-and-crohn-s-colitis-foundation-expand-strategic-partnership-to-establish-novel-registry-of-patients-with-inflammatory-bowel-disease-ibd

verily-and-lumea-announce-development-partnership-to-advance-digital-pathology-in-prostate-cancer

verily-and-swiss-re-broaden-strategic-relationship

verily-announces-1-billion-investment-round-to-fund-continued-growth-and-shares-changes-to-leadership-team

verily-announces-700-million-investment-round-to-accelerate-key-businesses-including-baseline-and-verily-health-platforms

Verily Announces New Customers and Partners for its Healthy at Work Program

verily-appoints-health-data-expert-and-former-fda-principal-deputy-commissioner-amy-abernethy-md-phd-as-president-of-verily-s-clinical-research-platforms

verily-appoints-industry-hr-leader-kerrie-peraino-as-chief-people-officer

verily-completes-acquisition-of-signalpath-expanding-company-s-clinical-research-capabilities-and-marking-company-s-first-major-acquisition34

verily-enhances-commercial-organization-with-the-appointment-of-lisa-greenbaum-as-chief-revenue-officer27

Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi to Transform Clinical Research

Verily launches Baseline Health System Consortium with Vanguard Health Systems

Verily Launches Healthy at Work Program to Support Organizations In Their Efforts to Ensure a Safe Return to Work and School

verily-opens-new-r-d-center-in-israel-focused-on-the-application-of-ai-in-healthcare

Verily Partners with Emory Healthcare to Analyze Medication and Lab Ordering Patterns for Improved Cost-Effectiveness and Operational Efficiency

verily-to-acquire-signalpath-expanding-company-s-clinical-research-capabilities

Verily launches Viewpoint Workbench to unify data and accelerate biomedical research

Walgreens Boots Alliance and Verily Announce Strategic Partnership to Innovate on New Solutions to Improve Health Outcomes

With New Name and Leader, Verily/ResMed Joint Venture Poised to Shine Light on America's Sleep Health Crisis

World's largest and most diverse skin and hair health study launches by L'Oréal and Verily

Verily leadership

Andrew Conrad, PhD, is the Executive Chairman and Founder of Verily. Previously, he was Chief Scientific Officer of Laboratory Corporation of America (LabCorp). Dr. Conrad co-founded the National Genetics Institute, where he served as Chief Scientific Officer. He is a Working Group Member on the Precision Medicine Initiative and a member of the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI) Scientific Advisory Board.

Executive Chairman and Founder

Andy Conrad

Stephen Gillett is the Chief Executive Officer at Verily, where he leads multi-disciplinary health, technology and business teams to advance the company's precision health purpose. Before his appointment as CEO, Stephen was Verily’s President and COO overseeing engineering, business and commercial operations. Prior to joining Verily, Stephen was co-founder and CEO of Chronicle, an Alphabet cybersecurity company that is now part of Google Cloud. He is an active advisor to GV and X. Prior to Alphabet, Stephen served as EVP, COO and board member at Symantec, a Fortune 500 Enterprise Technology Company. He also served as the EVP and President of Best Buy Digital and Business Operations, and was part of the founding Starbucks transformation leadership team as Chief Information Officer and General Manager of Digital Ventures. Stephen sits on the Board of Directors for Discord, Dutch Bros and the University of Oregon, Phil and Penny Knight Campus for Accelerating Scientific Impact. He was recognized by Amazon in 2019 as a best selling author for his book “From Simi Valley To Silicon Valley.” He holds an MBA from San Francisco State University and a BS from the University of Oregon.

Chief Executive Officer

Stephen Gillett 

Amy Abernethy is the President of Product Development and Chief Medical Officer at Verily, where she leads teams in the development and delivery of products that bridge the gap between clinical research and care. Dr. Abernethy was most recently Principal Deputy Commissioner of Food and Drugs of the US Food and Drug Administration (FDA) and the agency's acting Chief Information Officer. Prior to her role at the FDA, Dr. Abernethy was Chief Medical Officer, Chief Scientific Officer and Senior Vice President of Oncology of Flatiron Health. Before joining Flatiron, Dr. Abernethy was Professor of Medicine at Duke University School of Medicine and directed the Center for Learning Health Care in the Duke Clinical Research Institute and Duke Cancer Care Research Program in the Duke Cancer Institute. Dr. Abernethy is a hematologist/oncologist and palliative medicine physician who has authored more than 500 publications. She holds a BA in Biochemistry from the University of Pennsylvania, an MD from Duke University School of Medicine, and a PhD in Evidence Based Medicine and Informatics from Flinders University in Australia.

President of Product Development and Chief Medical Officer

Amy Abernethy

Scott Burke is the Chief Technology Officer at Verily, where he leads the company’s software and hardware engineering, AI and data science, and UX teams in the development of innovative products and platforms that power precision health. Prior to Verily, Scott was Co-founder and Chief Technology Officer for Helix, a leading population genomics company. Before Helix, Scott worked for nine years at Yahoo, most recently as Senior Vice President of Advertising and Data Platforms. Scott also previously led engineering teams at two mobile startups, Seven Networks and PacketHop, and was Vice President of Engineering for WebMD. Scott started his career as a computational physicist at Hewlett-Packard. He holds a bachelor’s degree in physics from Harvey Mudd College in Claremont, California.

Chief Technology Officer

Scott Burke

Andy Conn serves as the President and a member of the Board of Directors of Granular. Andy is a business leader with over 25 years of senior management experience and a track record of building a company from start-up to profitable strategic sale. For two years, Andy served as Granular’s Chief Operating Officer before moving into the role of President. Before joining Granular, Andy was a Co-founder/Director and served as COO and General Counsel of Square Knot Health, Inc., a disease management company focused on patients with chronic kidney disease. For 21 years Andy served as a COO and General Counsel of GeoBlue (an international specialty risk company), where he also served on the Board of Directors. Andy’s background also includes working for the Allegheny Health Network (now part of Highmark, Inc.) and practicing corporate law at Wolf, Block, Schorr & Solis-Cohen. Andy earned a B.A. from the University of Pennsylvania and a J.D. from the University of Pennsylvania Carey Law School.

President, Granular

Andy Conn

Utpal Koppikar is the Chief Financial Officer at Verily, where he's responsible for the finance, real estate and workplace services (REWS) and corporate development functions. Previously, Utpal was Executive Vice President and Chief Financial Officer at Atara Biotherapeutics where he oversaw the finance, information technology and investor relations functions. Prior to Atara, Utpal held several senior financial leadership positions at Gilead Sciences, including Vice President of Corporate and Operations Finance, where he was responsible for R&D, corporate, G&A, process development and manufacturing, and strategic sourcing. Before joining Gilead, Utpal served in multiple senior finance roles at Amgen. He began his career at Honeywell Aerospace (formerly AlliedSignal). Utpal holds a BS in Aerospace Engineering from the University of Maryland, an MS in aeronautical and astronautical engineering from Stanford University, and an MBA in finance and marketing from The Anderson School at UCLA.

Chief Financial Officer

Utpal Koppikar

Laura O’Donnell is the General Counsel at Verily where she leads the company’s legal function as the company furthers its precision health strategy. Previously, Laura served as McKesson’s first Chief Compliance Officer where she transformed the company’s approach to regulatory and operational excellence and spearheaded significant enterprise initiatives including the company’s COVID-19 Executive Response Team and its Drug Supply Chain Security Act enterprise governance strategies. Before joining McKesson, Laura held multiple roles in GE Healthcare’s legal department culminating in a promotion to Officer of General Electric and General Counsel of GE Healthcare. As General Counsel, Laura oversaw legal, compliance, clinical research, privacy and other functions across 120 countries. Laura also served as Zimmer Biomet’s first Chief Compliance Officer and began her legal career at Baker & Daniels (now Faegre Benson). Laura holds a Juris Doctor from Indiana University Maurer School of Law and a BA from James Madison College at Michigan State University.

Chief Legal Officer

Laura O’Donnell

Kerrie Peraino is the Chief People Officer at Verily, where she oversees all People Operations activities, including talent and leadership development, talent acquisition, learning, compensation and benefits, diversity and inclusion and employee relations. Prior to Verily, Kerrie was VP, People Operations, at Google, where she led frontline HR and delivered world-class HR services to over 130,000 Google employees. Before Google, Kerrie spent more than 20 years at American Express in the U.S. and the U.K., where, among other HR roles of increasing responsibility, she served as Chief Diversity Officer, Chief Talent Officer, and Senior Vice President of Global Talent Management. She holds a BA in Communications from Rutgers University and an MA in Corporate Communications from Seton Hall University.

Chief People Officer

Kerrie Peraino

Preston Simons is the Chief Information Officer at Verily, where he is responsible for building out our IT strategies, systems and processes. Previously, Preston was President and Managing Partner of Simons & Associates, LLC, where he consulted companies on driving business value through transformation of organizational practices, business processes, and technology alignment and implementation. He also specialized in merger and acquisition planning and coordination, IT transformation, integration, and technology strategy engagement. Preston has served in C-level positions for several decades across companies such as Aurora Healthcare, Abbott Laboratories (a Fortune 100 life sciences and medical device company), and Smithkline Beecham (GSK). He is a member of the Board of Governors for the Opus College of Business at the University of St. Thomas, Minnesota, and is an Advisory Board member for Infinity Systems, Inc. He is a certified Board Leadership Fellow of the National Association of Corporate Directors. Preston earned his MBA from the Booth School of Business at the University of Chicago and a BS degree in Management and Computer Science from the Illinois Institute of Technology.

Chief Information Officer

Preston Simons

Andrew Trister, MD, PhD, is the Chief Scientific Officer at Verily where he leads the company’s population health initiatives and provides expertise across Verily’s portfolio as the company furthers its precision health strategy. Previously, Andrew served as the Deputy Director of Digital Health and Artificial Intelligence at The Bill & Melinda Gates Foundation where he led the Foundation’s development and investment in digital health and artificial intelligence to address global health inequities. Prior to that, Andrew was a founding member of Apple’s Health team, where he led clinical research and machine learning with Apple partners. Andrew holds an M.D., Ph.D in bioengineering, an MSE and BSE in computer science, and a B.A. in biological basis of behavior from the University of Pennsylvania. He completed his clinical residency in radiation oncology at the University of Washington, with additional focus areas in medical and bioinformatics.